Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117669) titled 'Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: N-Fold, LLC
Condition:
Peanut Allergy
Intervention:
Drug: ENP-501
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: August 2025
Target Sample Size: 68
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117669
Published by HT Digital Content Services with permission ...